Lfa Lugano Financial Advisors Sa Bristol Myers Squibb CO Transaction History

Lfa Lugano Financial Advisors Sa

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $31,706 - $37,544	463 Added 115.75%	863 $62,000
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $29,048 - $31,992	400 New	400 $30,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $53,057 - $63,620	-863 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$53.63 - $62.52 $46,282 - $53,954	863 New	863 $54,000
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $2,076 - $2,335	-35 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $620,647 - $703,307	-10,749 Reduced 99.68%	35 $2,000
Q3 2020 Oct 23, 2020	BUY	$57.43 - $63.64 $17,286 - $19,155	301 Added 2.87%	10,784 $671,000
Q2 2020 Jul 10, 2020	SELL	$54.82 - $64.09 $239,563 - $280,073	-4,370 Reduced 29.42%	10,483 $612,000
Q1 2020 Apr 08, 2020	SELL	$46.4 - $67.43 $24,452 - $35,535	-527 Reduced 3.43%	14,853 $935,000
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $594,112 - $774,965	12,073 Added 365.07%	15,380 $987,000
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $4,462 - $4,934	100 Added 3.12%	3,307 $150,000
Q3 2018 Oct 11, 2018	BUY	$55.19 - $62.25 $81,736 - $92,192	1,481 Added 85.81%	3,207 $199,000
Q2 2018 Sep 04, 2018	SELL	$50.53 - $62.98 $4.71 Million - $5.86 Million	-93,117 Reduced 98.18%	1,726 $95,000
Q2 2018 Aug 30, 2018	BUY	$50.53 - $62.98 $4.79 Million - $5.97 Million	94,843 New	94,843 $95,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Lfa Lugano Financial Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Lfa Lugano Financial Advisors Sa with notifications on news.